Imaging biomarker of acute exacerbation of interstitial pneumonia after surgical resection of lung cancer

Imaging biomarker of acute exacerbation of interstitial pneumonia after surgical resection of lung cancer - Imaging biomarker of AE of IP after resection of lung cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000029661

Enrollment

360

Registered

2017-10-26

Start date

2017-08-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with lung cancer and interstitial pneumonia

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) the patients aged 20 years and over 2) the patients who underwent HRCT within 30 days before the resection of lung cancer

Exclusion criteria

Exclusion criteria: The patients whom the doctor in attendance judged to be unsuitable as a subject of the examination

Design outcomes

Primary

Measure	Time frame
Correlation of acute exacerbation of interstitial pneumonia (IP) with the following; pattern of IP, degree of IP, degree of emphysema, diameter of the pulmonary trunk, lung volume	—

Secondary

Measure	Time frame
Correlation of acute exacerbation of IP with the extent of honeycomb, ground glass opacity, consolidation, and blood chemistry study, pulmonary function test, the surgical procedure, preoperative medicine use	—

Countries

Japan

Contacts

Public ContactKazuhiro Nakayasu

Kondo photo process co. medical section

uu-360@rinsho-kenkyu.org06-4303-4913

Outcome results